LP 605 Pill - yellow & white capsule/oblong, 18mm
Pill with imprint LP 605 is Yellow & White, Capsule/Oblong and has been identified as Temozolomide 20 mg. It is supplied by Lotus Pharmaceutical Co., Ltd.
Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LP 605
Temozolomide
- Imprint
- LP 605
- Strength
- 20 mg
- Color
- Yellow & White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Lotus Pharmaceutical Co., Ltd.
- National Drug Code (NDC)
- 40051-0605
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
sodium starch glycolate type A corn,
tartaric acid,
stearic acid,
gelatin,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
See also:
More about temozolomide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- En español
Patient resources
- Temozolomide oral/injection drug information
- Temozolomide (Intravenous) (Advanced Reading)
- Temozolomide (Oral) (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.